Zoetis Inc. is a leading animal health company that engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, gene... Zoetis Inc. is a leading animal health company that engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions. It operates across seven major product categories, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. The company serves a diversified portfolio of species, encompassing livestock such as cattle, swine, poultry, fish, and sheep, as well as companion animals like dogs, cats, and horses. Zoetis Inc. holds the largest market share in the animal health industry, providing essential solutions for both production animals and pets worldwide. Its offerings support veterinarians, livestock producers, and pet owners by addressing key health needs in these sectors. Founded in 2013 and headquartered in Parsippany, New Jersey, Zoetis Inc. plays a pivotal role in advancing animal care through innovative products and services.
Based on current regulatory requirements, Zoetis is not required to report EU
Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU
Taxonomy data review for this company.
If you believe this assessment should be revisited, you may submit a data coverage request
and our team will review the company's regulatory applicability.